Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 Years' follow-up

International Journal of Obesity

Volumn 28, Issue 12, 2004, Pages 1600-1606

  Lubrano, C ^a   Cornoldi, A ^a   Pili, M ^a   Falcone, S ^a   Brandetti, F ^a   Fabbrini, E ^a   Ginanni Corradini, S ^a   Eramo, A ^a   Marini, M ^a   Migliaccio, S ^a   Giancotti, V ^a   Badiali, M ^a   Falsetto, N ^a   Prossomariti, G ^a   Spera, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bypass; Cardiovascular; Disease; Risk factors

Indexed keywords

FIBRINOGEN; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; BILE DUCT BYPASS; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; FIBRINOGEN METABOLISM; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MALE; MORBID OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; JEJUNOILEAL BYPASS; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; RISK FACTORS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 9444249279     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802782     Document Type: Article

References (46)

1. Rossner S. Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 2002; 26: S2-S4.
2. Hu FB. Overweight and obesity in women: health risks and consequences. J Womens Health 2003; 12: 163-172.
3. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series, Vol 894. WHO: Geneva; 2000. pp 1-253.
4. Lebovitz HE. The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl 2003; 134: 18-27.
5. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 2003; 108: 420-425.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
7. Zimmet PZ. Kelly West Lecture 1991: challenges in diabetes epidemiology: from West to the rest. Diabetes Care 1992; 15: 232-252.
8. Kaplan NM. The deadly quartet: upper body adiposity, glucose intolerance, hypertriglyceridaemia and hypertension. Arch Intern Med 1989; 149: 1514-1520.
9. Kolanowski J. Pathophysiology and treatment of the obesity-related arterial hypertension. Acta Clin Belg 1992; 47 (Suppl 14): 18-25.
10. Avellone G, Di Garbo V, Cordova R, Ranelli G, De Simone R, Bompiani G. Coagulation, fibrinolysis, and haemorheology in premenopausal obese women with different body fat distribution. Thromb Res 1994; 75: 223-231.
11. Haheim LL, Holme I, Hjermann I, Leven P. Risk factors of stroke incidence and mortality. A 12-year follow up of the Oslo Study. Stroke 1993; 24: 1484-1489.
12. Barrett-Connor E. Obesity, atherosclerosis and coronary artery disease. Ann Intern Med 1985; 103: 1010-1019.
13. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity. JAMA 1987; 257: 353-358.
14. Bray GA, Gray DS. Obesity: Part II. Treatment. West J Med 1988; 149: 555-571.
15. Garrow JS. Morbid obesity: medical or surgical treatment? The case for medical treatment. Int J Obes 1987; 11: 1-4.
16. Schurgin S, Siegel RD. Pharmacotherapy of obesity: an update. Nutr Clin Care 2003; 6: 27-37.
17. Weigle DS. Pharmacological therapy of obesity: past, present, and future. J Clin Endocrinol Metab 2003; 88: 2462-2469.
18. LIGIO '99 II.D.6.6. p 15.
19. Eriksson F. Biliointestinal by-pass. Int J Obes 1981; 5: 437-447.
20. Bomann L, Domellof L. Biliary-intestinal by-pass in the treatment of obesity: long term follow up. Eur J Surg 1998; 164: 943-949.
21. Doldi SB. Bilio-intestinal by-pass: another surgical option. Obes Surg 1998; 8: 566-569.
22. Badiali M, D'Agostini A, Filippis AM, Corradini SG, Grossi A, Eramo A, Spera G, Lubrano C, Massa R, Scopinaro F. Patency of anastomoses after bilio-intestinal bypass: radioisotope demonstration. Obes Surg 2001; 11: 615-618.
23. Galati G, Izzo L, Binda B, De Cesare A, Fiori E, Bononi M, Masoni L, Badiali M. Biliary-intestinal bypass in the treatment of severe obesity: personal experience with 23 patients. Minerva Chir 2001; 56: 345-349.
24. Cugini P, Spera G, De Rosa R, Falcone S, Pandolfi C, Badiali M. The orexigram in patients affected by morbid obesity: a preliminary report on daily high sensation before bariatric surgery. Eat Weight Disord 2003; 8: 194-200.
25. Pietrobelli A, Formica C, Wang Z, Heymsfield SB. Dual-energy X-ray absorptiometry body composition model: review of concepts. Am J Physiol 1996; 271 (Endocrinology Metabolism 34): E941-E951.
26. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med 1998; 15: 539-553.
27. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23 (Suppl 1): S4-S19.
28. Poulter N. Global risk of cardiovascular disease. Heart 2003; 89 (Suppl 2): ii2-ii5 discussion ii5-ii7.
29. Della Guardia P, Grossi A, Elisei W, Eramo A, de Santis AD, Attili AF, Genco A, Basso N, Ginanni Corradini SG. Plasma lipoproteins affect rate of cholesterol absorbed from bile by gallbladder: preliminary data. Ital J Gastroenterol Hepatol 1999; 31: 587-592.
30. Ginanni Corradini S, Eramo AR, Grossi A, D'Agostini A, Scopinaro F, Lubrano C, Spera G. The biliary-intestinal by-pass lowers total cholesterol and LDL-cholesterol plasma levels by reducing biliary cholesterol absorption. Hepato-Gastroenterology 1999; 46 (Suppl III): IV10.
31. Ginanni Corradini S, Eramo AR, Grossi A, D'Agostini A, Scopinaro F, Lubrano C, Spera G. Reducing the absorption of biliary cholesterol with a biliary-intestinal by-pass lowers the total and LDL cholesterol plasma levels. Hepato-Gastroenterology 1999; 30: 523A.
32. Busetto L, Pisent C, Rinaldi D, Longhin PL, Segato G, De Marchi F, Foletto M, Favretti F, Lise M, Enzi G. Variations in lipid levels in morbidly obese patients operated with the LAP-BAND adjustable gastric banding system: effects of different levels of weight loss. Obes Surg 2000; 10: 569-577.
33. Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg 2000; 4: 464-469.
34. Avellone G, Di Garbo V, Cordova R, Ranelli G, De Simone R, Bompiani G. Coagulation, fibrinolysis, and haemorheology in premenopausal obese women with different body fat distribution. Thromb Res 1994; 75: 223-231.
35. Rissanen P, Vahtera E, Krusius T, Uusitupa M, Rissanen A. Weight change and blood coagulability and fibrinolysis in healthy obese women. Int J Obes Relat Metab Disord 2001; 25: 212-218.
36. Bonora E, Micciolo R, Ghiatas AA, Lancaster JL, Alyassin A, Muggeo M, De Fronzo RA. It is possible to derive a reliable estimate of human visceral and subcutaneous abdominal tissue from simple anthropometric measurements? Metabolism 1995; 44: 1617-1625.
37. Lancaster JL, Ghiatas AA, Alyassin A, Kilcoyne RF, Bonora E, De Fronzo RA. Measurement of abdominal fat with T1-weighted MR image. J Magn Reson Imag 1991; 1: 363-369.
38. Staessen J, Fagard R, Amery A. The relation between body weight and blood pressure. Hum Hypertens 1988; 2: 207-217.
39. Selby JV, Friedman GD, Quesenberry Jr CP. Precursor of essential hypertension. The role of body fat distribution pattern. Am J Epidemiol 1989; 129: 43-53.
40. Letiexhe MR, Scheen AJ, Gerard PL, Desaive C, Lefebvre PJ. Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clin Endocrinol Metab 1995; 80: 364-369.
41. Scopinaro N, Marinari G, Adami G, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A. The effect of bilio-pancreatic diversion on glucose and cholesterol metabolism. Obes Surg 1998; 8: 151.
42. Pories W, Hickey MS, MacDonald K. Prevention and control of type 2 diabetes mellitus with gastric by-pass surgery. Int J Obes Relat Metab Disord 1998; 22 (Suppl S85): 35.
43. De Simone G, Devereux RB, Palmieri V, Roman MJ, Celentano A, Welty TK, Fabsitz RR, Contaldo F, Howard BV. Relation of insulin resistance to markers of preclinical cardiovascular disease: the Strong Heart Study. Nutr Metab Cardiovasc Dis 2003; 13: 140-147.
44. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003; 115 (Suppl 8A): 37S-41S.
45. Brochier ML, Arwidson P. Coronary heart disease risk factors in women. Eur Heart J 1998; 19 (Suppl A): A45-A52.
46. Anderson JW, Hamilton CC, Brinkman-Kaplan V. Benefits and risks of an intensive very-low-calorie-diet program for severe obesity. Am J Gastroenterol 1992; 87: 6-15.